Chemistry Wealth Management LLC Has $1.03 Million Stock Holdings in The Procter & Gamble Company (NYSE:PG)

Chemistry Wealth Management LLC increased its position in The Procter & Gamble Company (NYSE:PG) by 4.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 6,115 shares of the company’s stock after purchasing an additional 278 shares during the quarter. Chemistry Wealth Management LLC’s holdings in Procter & Gamble were worth $1,025,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Itau Unibanco Holding S.A. acquired a new stake in Procter & Gamble in the second quarter worth about $28,000. RPg Family Wealth Advisory LLC acquired a new position in shares of Procter & Gamble during the 3rd quarter worth about $33,000. Costello Asset Management INC grew its position in shares of Procter & Gamble by 2,142.9% during the 3rd quarter. Costello Asset Management INC now owns 314 shares of the company’s stock worth $54,000 after buying an additional 300 shares during the period. William B. Walkup & Associates Inc. bought a new position in shares of Procter & Gamble during the 2nd quarter valued at about $58,000. Finally, Mendota Financial Group LLC lifted its holdings in shares of Procter & Gamble by 58.0% during the 4th quarter. Mendota Financial Group LLC now owns 376 shares of the company’s stock valued at $63,000 after purchasing an additional 138 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Stock Up 0.5 %

PG stock opened at $161.35 on Friday. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The business’s 50 day simple moving average is $169.19 and its 200 day simple moving average is $169.38. The Procter & Gamble Company has a 1-year low of $146.28 and a 1-year high of $180.43. The firm has a market capitalization of $379.98 billion, a PE ratio of 27.82, a PEG ratio of 3.41 and a beta of 0.45.

Procter & Gamble (NYSE:PG) last issued its quarterly earnings data on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.03. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The firm had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same period in the prior year, the firm posted $1.83 EPS. The company’s revenue for the quarter was down .6% on a year-over-year basis. As a group, research analysts anticipate that The Procter & Gamble Company will post 6.93 EPS for the current year.

Procter & Gamble Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 18th. Shareholders of record on Friday, January 24th will be issued a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a yield of 2.50%. The ex-dividend date of this dividend is Friday, January 24th. Procter & Gamble’s dividend payout ratio is 69.48%.

Insider Buying and Selling at Procter & Gamble

In other news, CEO R. Alexandra Keith sold 1,992 shares of the company’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total transaction of $338,640.00. Following the completion of the sale, the chief executive officer now directly owns 13,783 shares in the company, valued at approximately $2,343,110. This represents a 12.63 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Gary A. Coombe sold 47,847 shares of the company’s stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the sale, the chief executive officer now owns 39,977 shares of the company’s stock, valued at approximately $7,189,463.68. The trade was a 54.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 75,439 shares of company stock valued at $13,317,460 in the last ninety days. 0.18% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several research firms have recently weighed in on PG. JPMorgan Chase & Co. cut their price objective on Procter & Gamble from $186.00 to $181.00 and set an “overweight” rating on the stock in a report on Thursday. Barclays cut their price objective on Procter & Gamble from $163.00 to $155.00 and set an “equal weight” rating on the stock in a report on Friday. Morgan Stanley boosted their target price on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research note on Monday, October 21st. Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Finally, Stifel Nicolaus dropped their price objective on Procter & Gamble from $167.00 to $161.00 and set a “hold” rating on the stock in a research note on Friday. Eight equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $179.65.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.